The Act-F Trial: Does active follow-up of invitation lead to higher participation in bowel screening by Maori, Pacific and Asians?
Ontology highlight
ABSTRACT: Interventions: The intervention consists of a delay of 8 weeks in commencing the standard Active Follow (AF) pathway invitees to bowel screening who have not returned a test kit within 4 weeks of being sent an invitation letter. The standard AF service consists of the following. Eligible individuals are identified and extracted from the Bowel Screening Pilot register. This data is inserted into an Access (Registered Trademark) database. The database is available to the team of Community coordinators who carry out the AF activities. They use the database to filter the population according to the ethnicity that they serve. The Coordination Centre employs 0.4 FTE of Maori Community Coordinators, 0.4 FTE of Samoan/Other Pacific Coordinators and 0.9 FTE of Asian Coordinators. They phone the individuals and record the outcome of the calls. Key Performance Indicators set by the MOH require a minimum of 3 phone calls to be made within a 4 week period, one of which must be made after regular working hours. If a number appears to be invalid other data sources are searched for current contact details. These include the hospital systems, the Primary Health Organisation age/sex registers, the patient’s GP practice, and contacts the Community Coordinators have with their own communities. In the intervention group this active follow-up activity commences 12 weeks after being sent an invitation letter for bowel screening rather than 4 weeks after as in the control group.
Primary outcome(s): The primary endpoint of the study is the overall difference in the participation rate of people in the intervention group compared with the control group, [For each invitee, the primary outcome will be measured at 8 weeks from the date at which they were randomly assigned to the group (and for the intervention group with delayed AF, it will measured prior to their receiving the AF service). ]
Study Design: Purpose: Diagnosis; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy
DISEASE(S): Immunochemical Faecal Occult Blood Screening For Colorectal Cancer,Public Health-health Service Research,Colorectal Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)
PROVIDER: 2464529 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA